🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Irva E. Veillard

Massachusetts General Hospital

ORCID: 0000-0003-4011-0039

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Dual Fluorescence Isogenic Synthetic Lethal Kinase Screen and High-Content Secondary Screening for MUC16/CA125-Selective Agents”.

Dual Fluorescence Isogenic Synthetic Lethal Kinase Screen and High-Content Secondary Screening for MUC16/CA125-Selective Agents

Molecular Cancer Therapeutics(2022)10.1158/1535-7163.mct-21-0572

N/A

0DataRank · unranked

0 citations

Mengyao Xu, Stephanie Eng, Guangli Yang, Robin Manson, Néstor Rosales +9 more

Data from Dual Fluorescence Isogenic Synthetic Lethal Kinase Screen and High-Content Secondary Screening for MUC16/CA125-Selective Agents

(2023)10.1158/1535-7163.c.6543348

N/A

0DataRank · unranked

0 citations

Mengyao Xu, Stephanie Eng, Guangli Yang, Robin Manson, Néstor Rosales +9 more

Targeting Galectin 3 illuminates its contributions to the pathology of uterine serous carcinoma

British Journal of Cancer(2024)10.1038/s41416-024-02621-x

N/A

0DataRank · unranked

14 citations

Dominique T. Zarrella, Venkatesh Pooladanda, Maryam Azimi, Eugene Kim, Shaan Kumar +15 more